Gao Yu-Jing, Zeng Zhao-hua, Teoh Kevin, Sharma Arya M, Abouzahr Labib, Cybulsky Irene, Lamy Andre, Semelhago Lloyd, Lee Robert M K W
Department of Anaesthesia, McMaster University, Hamilton, Ontario, Canada.
J Thorac Cardiovasc Surg. 2005 Oct;130(4):1130-6. doi: 10.1016/j.jtcvs.2005.05.028.
Recent studies have shown that perivascular adipose tissue from the rat aorta secretes a substance that can dilate the aorta. The purpose of the present study was to examine whether this vasodilator is also present in human internal thoracic arteries.
Vascular function of human internal thoracic arteries with and without perivascular adipose tissue was assessed with wire myography, and morphology was examined with light microscopy.
The presence of perivascular adipose tissue attenuated the maximal contraction to U 46619 and the contraction to phenylephrine (1 micromol/L) by 37% and 24%, respectively. Transfer of the solution incubated with a perivascular adipose tissue-intact vessel (donor) to a vessel without perivascular adipose tissue (recipient) induced a significant relaxation (36%) in the recipient artery precontracted with phenylephrine. Transfer of incubation solution with perivascular adipose tissue alone also induced a relaxation response in the recipient vessel (37%). The relaxation of the recipient artery induced by the transfer of incubation solution from the donor (artery with intact perivascular adipose tissue or perivascular adipose tissue alone) was absent in vessels precontracted by KCl (60 mmol/L) and was prevented by calcium-dependent potassium channel blockers (tetraethylammonium chloride, 1 mmol/L; iberiotoxin, 100 nmol/L), but not by the voltage-dependent potassium channel blocker 4-aminopyridine (1 mmol/L) and the adenosine triphosphate-dependent potassium channel blocker glibenclamide (10 micromol/L).
Perivascular adipose tissue in human internal thoracic arteries releases a transferable relaxation factor that acts through the activation of calcium-dependent potassium channels. Because perivascular adipose tissue is often removed in coronary artery bypass grafting, retaining perivascular adipose tissue might be helpful in reducing the occurrence of vasospasm of the graft vessels.
近期研究表明,大鼠主动脉的血管周围脂肪组织分泌一种可使主动脉扩张的物质。本研究的目的是检测这种血管舒张剂是否也存在于人类胸廓内动脉中。
采用线肌张力描记法评估有无血管周围脂肪组织的人类胸廓内动脉的血管功能,并用光学显微镜检查其形态。
血管周围脂肪组织的存在使对U 46619的最大收缩以及对去氧肾上腺素(1微摩尔/升)的收缩分别减弱了37%和24%。将与带有完整血管周围脂肪组织的血管(供体)一起孵育的溶液转移至没有血管周围脂肪组织的血管(受体),可使预先用去氧肾上腺素收缩的受体动脉产生显著舒张(36%)。仅用血管周围脂肪组织孵育溶液的转移也可使受体血管产生舒张反应(37%)。由供体(带有完整血管周围脂肪组织的动脉或仅血管周围脂肪组织)转移孵育溶液所诱导的受体动脉舒张,在用氯化钾(60毫摩尔/升)预收缩的血管中不存在,且可被钙依赖性钾通道阻滞剂(氯化四乙铵,1毫摩尔/升;iberiotoxin,100纳摩尔/升)阻断,但不能被电压依赖性钾通道阻滞剂4-氨基吡啶(1毫摩尔/升)和三磷酸腺苷依赖性钾通道阻滞剂格列本脲(10微摩尔/升)阻断。
人类胸廓内动脉的血管周围脂肪组织释放一种可转移的舒张因子,该因子通过激活钙依赖性钾通道发挥作用。由于在冠状动脉旁路移植术中血管周围脂肪组织常被去除,保留血管周围脂肪组织可能有助于减少移植血管血管痉挛的发生。